Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 14 results:
[ Συντάκτης] Τίτλος Τύπος Έτος Φίλτρα: Συντάκτης is Apostolidis, Apostolos [Clear All Filters]
Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms: results from the hospitalised and outpatients' profile and expectations study..
Eur Urol. 56(6), 937-47.
(2009). Is there "brain OAB" and how can we recognize it? International Consultation on Incontinence-Research Society (ICI-RS) 2017..
Neurourol Urodyn. 37(S4), S38-S45.
(2018). Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?.
Curr Drug Targets. 16(11), 1187-97.
(2015). Is there enough evidence to support sacral neuromodulation as a viable treatment option in children and adolescents with neurogenic lower urinary tract dysfunction?.
World J Urol. 37(12), 2811-2812.
(2019). Combination treatments for overactive bladder refractory to first-line pharmacotherapy: do they meet expectations?.
BJU Int. 120(4), 459-460.
(2017). Words of wisdom. Re: Intrathecal administration of botulinum toxin type a improves urinary bladder function and reduces pain in rats with cystitis..
Eur Urol. 67(4), 816.
(2015). Neurourological Management After Failed Intradetrusor OnabotulinumtoxinA Injections..
Eur Urol Focus. 6(5), 814-816.
(2020). Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015)..
Neurourol Urodyn. 36(4), 882-893.
(2017). Male lower urinary tract symptoms: a riddle waiting to be solved..
Eur Urol. 64(3), 408-10.
(2013). Intravesical Botox for overactive bladder; how to minimize complications and manage failures..
Curr Drug Targets.
(2020). How does lower urinary tract dysfunction (LUTD) affect sexual function in men and women? ICI-RS 2015-Part 2..
Neurourol Urodyn. 36(4), 869-875.
(2017). An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity..
World J Urol. 31(6), 1469-74.
(2013). Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage Failures.
Current Drug Targets. 21(15), 1527 - 1536.
(2020). Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014..
Neurourol Urodyn. 35(2), 293-8.
(2016).